Inventor · disambiguated record
John Kokai-Kun
Also filed as: KOKAI-KUN JOHN F · KOKAI-KUN JOHN FITZGERALD
2 granted patents·10 pending applications·19 citations·filing 2002–2011
59Inventor score
Top patents by PatentIndex Score
12 records- 0183US7169903B2Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteriaBIOSYNEXUS INC·Filed 2002·Granted Jan 30, 2007·15 cites·12 claims
- 0262US2008014202A1Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteriaBIOSYNEXUS INC·Filed 2006·Application pending·0 cites
- 0358US2010221237A1Enzyme disruption of bacterial biofilmsBIOSYNEXUS INC·Filed 2009·Application pending·0 cites
- 0456US7572439B2Enzyme disruption of bacterial biofilmsBIOSYNEXUS INC·Filed 2003·Granted Aug 11, 2009·4 cites·50 claims
- 0553US2007238652A1Neutralization of bacterial sporesBIOSYNEXUS INC·Filed 2007·Application pending·0 cites
- 0650US2007071682A1Methods for testing vaccine candidates against bacterial infection in rodentsKOKAI-KUN JOHN F·Filed 2006·Application pending·0 cites
- 0747US2005118159A1Truncated lysostaphin molecule with enhanced staphylolytic activityFiled 2002·Application pending·0 cites
- 0846US2004247605A1Wall teichoic acid as a target for anti-staphylococcal therapies and vaccinesFiled 2003·Application pending·0 cites
- 0945US2004191170A1Animal model for enteric pathogensFiled 2002·Application pending·0 cites
- 1041US2003224000A1Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodiesFiled 2002·Application pending·0 cites
- 1140US2003211995A1Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphinFiled 2002·Application pending·0 cites
- 1234US2011236399A1Compositions and methods for prophylactic and therapeutic treatment of infectionBIOSYNEXUS INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Kokai-Kun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →